Cargando…

Transcriptomic analysis of biofilm formation in strains of Clostridioides difficile associated with recurrent and non-recurrent infection reveals potential candidate markers for recurrence

The transcriptomic profile in a biofilm model of ribotypes (RT) 001 and 027 associated with recurrent Clostridioides difficile infection (R-CDI) and not associated with recurrent (NR)-CDI was analyzed to identify genes that may favor the recurrence. Twenty strains were selected, 10 RT001 and 10 RT02...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rubio-Mendoza, Daira, Córdova-Fletes, Carlos, Martínez-Meléndez, Adrián, Morfín-Otero, Rayo, Maldonado-Garza, Héctor Jesús, Garza-González, Elvira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399906/ https://www.ncbi.nlm.nih.gov/pubmed/37535660 http://dx.doi.org/10.1371/journal.pone.0289593

Ejemplares similares

Review of the Impact of Biofilm Formation on Recurrent Clostridioides difficile Infection
por: Rubio-Mendoza, Daira, et al.
Publicado: (2023)

An Update on Clostridioides difficile Binary Toxin
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2022)

2407. Overexpression of Virulence Factors in Biofilm from Recurrent Clostridium (Clostridioides) difficile Infection Isolates.
por: Tijerina, Laura, et al.
Publicado: (2019)

High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2019)

Virulence Factors of Clostridioides (Clostridium) difficile Linked to Recurrent Infections
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2019)

Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT) vs. FMT Enriched with Lactobacillus in the Treatment of Recurrent Clostridioides difficile Infection
por: Garza-González, Elvira, et al.
Publicado: (2019)

Current knowledge on the laboratory diagnosis of Clostridium difficile infection
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2017)

502. Enhanced Sporulation and Vancomycin Resistance Associated With Clostridium difficile From Recurrent Infections
por: Tijerina-Rodriguez, Laura E, et al.
Publicado: (2018)

Clinical characteristics associated with the severity of Clostridium [Clostridioides] difficile infection in a tertiary teaching hospital from Mexico
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2022)

Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection
por: Normington, Charmaine, et al.
Publicado: (2021)

Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens
por: Cruz-López, Flora, et al.
Publicado: (2022)

Look What the Cat Dragged in! Recurrent Clostridioides difficile from a Household Cat
por: Garza, Manuel A., et al.
Publicado: (2023)

Wolf in Sheep’s Clothing: Clostridioides difficile Biofilm as a Reservoir for Recurrent Infections
por: Meza-Torres, Jazmin, et al.
Publicado: (2021)

Gut metabolites predict Clostridioides difficile recurrence
por: Dawkins, Jennifer J., et al.
Publicado: (2022)

Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection
por: Castro-Córdova, Pablo, et al.
Publicado: (2021)

Microbiota in Clostridioides difficile-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
por: Gazzola, Alessandra, et al.
Publicado: (2020)

Risk Factors Associated with Recurrent Clostridioides difficile Infection
por: Negrut, Nicoleta, et al.
Publicado: (2020)

Epidemiology of community-acquired and recurrent Clostridioides difficile infection
por: Fu, Yichun, et al.
Publicado: (2021)

400. Rehospitalization of Patients for Recurrent Clostridioides difficile Infection
por: Drwiega, Emily, et al.
Publicado: (2022)

2026. Phenotypic and Molecular Characterization of Drug Resistance and Biofilm Production in Stenotrophomonas maltophilia Obtained in a 10-Year Period from a Mexican Hospital
por: Flores-Treviño, Samantha, et al.
Publicado: (2018)

Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital
por: Morfin-Otero, Rayo, et al.
Publicado: (2015)

Author Correction: Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection
por: Castro-Córdova, Pablo, et al.
Publicado: (2022)

789. Evaluation of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence
por: Johnson, Tanner M, et al.
Publicado: (2020)

Pet Ownership Protects Against Recurrence of Clostridioides difficile Infection
por: Redding, Laurel E, et al.
Publicado: (2020)

Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
por: Sandhu, Avnish, et al.
Publicado: (2021)

Pseudomembranes on colostomy in a patient with recurrent Clostridioides difficile infection
por: Ueda, Hideki, et al.
Publicado: (2023)

Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection
por: Escudero-Sánchez, Rosa, et al.
Publicado: (2020)

792. Evaluation of Persistent Diarrhea and Recurrence Following Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
por: Boton, Noah, et al.
Publicado: (2020)

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
por: Kullar, Ravina, et al.
Publicado: (2020)

Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis
por: Phatharacharukul, Parkpoom, et al.
Publicado: (2020)

Health-related quality of life in patients with recurrent Clostridioides difficile infections
por: Hammeken, Lianna H., et al.
Publicado: (2022)

Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Soveral, Lucas F, et al.
Publicado: (2022)

Fidaxomicin to prevent recurrent Clostridioides difficile: what will it cost in the USA and Canada?
por: Patel, Devangi, et al.
Publicado: (2023)

The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection
por: Seekatz, Anna Maria, et al.
Publicado: (2022)

Treatment issues in recurrent Clostridioides difficile infections and the possible role of germinants
por: Budi, Noah, et al.
Publicado: (2020)

Utilizing vancomycin as secondary prophylaxis for the prevention of recurrent Clostridioides difficile infection
por: Kristen, Zeitler, et al.
Publicado: (2023)

Increasing rates of Clostridium difficile infection in Mexican hospitals
por: Dávila, Laura Palau, et al.
Publicado: (2017)

Analysis of the impact of secondary prophylaxis on Clostridioides difficile recurrence in critically ill adults
por: Connor, Kathryn A, et al.
Publicado: (2020)

Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections
por: Granata, Guido, et al.
Publicado: (2021)

722. Effectiveness of Fidaxomicin versus Oral Vancomycin in the Treatment of Recurrent Clostridioides difficile
por: Rinaldi, Alyssa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_keqn15217e2r4rauj171rgp1jh